Document:

EMPLOYMENT
AGREEMENT

 

THIS
EMPLOYMENT AGREEMENT (the “Agreement”), dated and effective as of the ____day of _____________ , 2017 (the “Effective
Date”), is entered by and between Scythian Biosciences, Corp., a body corporate formed under the Business Corporations
Act of Canada (the “Company”), with a registered office located at ______________________and Jonathan Gilbert
(the “Executive”) having an address at 36 Sycamore Lane, Roslyn Heights, New York 11577. The Company and the Executive
may hereinafter be referred to individually as a “Party” or collectively as the “Parties”.

 

WITNESSETH:

 

WHEREAS,
the Company desires to procure the services of the Executive as its Chief Executive Officer, and the Executive desires to
provide such services to the Company, all upon the terms and conditions hereinafter set forth; and

 

WHEREAS,
the Company recognizes that the Executive, acting through Adroit Services Ltd, has provided substantial valuable services
to the Company and/or its affiliates, and has specific expertise relating to the Company’s business; and

 

WHEREAS,
the Parties agree that this Agreement is intended to supersede the Executive Consultant Agreement made between the Executive
acting through Adroit Services Ltd and Scythian Biosciences, Inc. dated effective as of December 4, 2014 (“Executive Consultant
Agreement”), as amended July 31, 2015;

 

NOW,
THEREFORE, in consideration of the mutual promises contained herein, and for other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, and intending to be legally bound hereby, the Company and the Executive agree
as follows:

 

	1.	Employment

 

The
Company agrees to employ the Executive as the Chief Executive Officer of the Company, and the Executive accepts the employment,
on the terms and conditions hereafter set forth. The employment shall be on a full-time basis with the Executive performing his
duties hereunder primarily at the Company’s New York, NY office or elsewhere at Executive’s discretion. The Executive
will devote such time as shall be required to satisfy the duties of the position, including at the Company’s expense, periodic
visits to research centers conducting the Company’s medical research and such other locations as may be necessary. It is
expressly understood and acknowledged that Executive may have other employment outside of this position, provided always that
the Executive shall refrain from any other employment or involvements which may be harmful to or competitive with the Company,
or would in any way constitute (or could reasonably be perceived to constitute) a conflict of interest with the Executive’s
obligations under this Agreement.

 

Subject
to the foregoing, during the Employment Term and any Renewal Terms, as those terms are hereinafter defined, when working for Company,
the Executive shall devote his best efforts, knowledge and skill to the Company’s business and affairs. The Executive will
have the rights, duties and obligations customarily associated with the position of Chief Executive Officer of a comparably sized
company, with particular focus on assisting the Board of Directors in Managing the activities of the Company The Executive will
report directly to the Board of Directors of the Company.

 

    	 	 	 Page 1 to 19

     

    

 

	2.	Term
                                         of Employment: Renewals

 

		(a)	Term

 

	 	(i)	The
    employment hereunder shall commence on the date of execution of this agreement (the “Commencement Date”), and
    shall continue until the end of Three (3) years from the Commencement Date, unless sooner terminated pursuant to the terms
    of this Agreement (the “Initial Term”). The “Employment Term” is defined as the Initial Term plus
    any “Renewal Terms” as such term is defined in the next section.
	 	 	 
	 	(ii)	Automatic
    Renewals. After the Initial Term, this Agreement shall automatically renew for subsequent terms of One (1) year (each
    subsequent One (1) year period termed a “Renewal Term”) unless either the Company or the Executive provides to
    the other not less than Thirty (30) days prior to the expiration of the then existing Employment Term written notice of non-renewal.
    The terms and conditions of this Agreement shall continue to apply to each such Renewal Term as part of the Employment Term,
    except as expressly agreed otherwise by the Parties in writing at the time of such renewal.

 

	3.	Compensation

 

The
remuneration of the Executive will be at the fixed rate of salary per annum (“Base Salary”) as set out in Schedule
1 to this Agreement, payable in accordance with the Company’s normal payroll policies in effect from time to time. The Executive
will be entitled to those additional benefits set out in Schedule 1 to this Agreement.

 

The
Executive will also be entitled to participate in the stock option and/or equity stock ownership programs for ownership in the
Company as provided for in Schedule 2 to this Agreement in such amounts as to be reasonably agreed upon between Executive and
the Company once the amount of stock options and/or equity that are available for distribution to Executive is determined.

 

    	 	 	 Page 2 to 19

     

    

 

	4.	Termination

 

In
the event of non-renewal, this Agreement shall automatically terminate at the end of the Employment Term, unless sooner terminated
in accordance with this Section 4.

 

		(a)	Definitions.
                                         For purposes of this Agreement:

 

	 	(i)	“Cause”
    means: (i) the occurrence of an intentional material breach of any material covenant contained in this Agreement by an act
    of gross misconduct by the Executive and the failure to cure such alleged breach after Thirty (30) days prior
    written notice to the Executive specifying both the basis of such breach and expressly stating what remedial
    action is required to cure such breach (provided that the Company reserves the right to suspend the Executive with pay at
    any time during and pending the expiry of such cure period); or (ii) the Executive’s theft or embezzlement from the
    Company during the Term of this Agreement, or (iii) the Executive’s conviction of a felony or indictable offence under
    the laws of Canada or the United States; or (iv) a final order by the Canadian provincial securities commission pertaining
    to the Executive that could reasonably be expected to impair or impede the Executive from performing the functions and duties
    contemplated by this Agreement.
	 	 	 
	 	(ii)	“Change
    of Control” means the occurrence of one of the following events after the Commencement Date: [(1) the acquisition by
    any “Person” (as such term is defined in Section 3(a)(9) of the Securities Exchange Act of 1934 (the “Exchange
    Act”) or Part XX of the Securities Act (Ontario), directly or indirectly, of a sufficient amount of the combined
    voting power of the then outstanding securities entitled to vote generally in the election of directors of the Company that
    such acquisition results in such Person owing in excess of 35% of such combined voting power or (2) any merger, consolidation,
    reorganization, recapitalization, tender or exchange offer or any other transaction with or effecting the Company as a result
    of which a Person owning more than 35% of the combined voting power of the then outstanding securities entitled to vote generally
    in the election of the directors of the Company, or (3) the sale, lease, exchange, transfer or other disposition to any Person
    of all or substantially all of the assets of the Company and its consolidated subsidiaries.
	 	 	 
	 	(iii)	“Good
    Reason Event” means any of the following without the Executive’s written consent of the following events:

 

    	 	 	 Page 3 to 19

     

    

 

	 	(A)	a
    material reduction (of greater than 10% in the aggregate) in his Base Salary, Annual Bonus and/or benefits;
	 	 	 
	 	(B)	a
    material diminution of his duties, responsibilities or reporting responsibility as Chief Operating Officer of the Company,;
	 	 	 
	 	(C)	a
    breach by the Company or any successor of any material provision of this Agreement; or,
	 	 	 
	 	(D)	a
    requirement that Executive spend more than 10% of his business hours at a location other than Executive’s principal
    location in effect prior to the Change of Control.

 

	 	(iv)	“Termination
    Date” means the date designated by the Company as the effective day on which the Executive’s employment ceases
    for any reason whatsoever (regardless of any period of notice or compensation in lieu or severance to which the Executive
    may claim to be or be entitled under statute, contract or otherwise at law).

 

		(b)	Termination
                                         by Company

 

	 	(i)	Termination
    For Cause. The employment of Executive may be terminated by the Company at any time for Cause. To be effective the determination
    of Cause for termination of Executive’s employment hereunder must be made by a majority of the Board of Directors after
    notice to Executive and an opportunity for Executive to be heard by the Board of Directors. Upon termination for Cause, Section
    4(f) shall apply. In the event that the Company terminates Executive for Cause and a final and binding decision is rendered
    in any legal proceeding finding the termination was not properly for Cause, the Executive shall be entitled to all sums set
    forth in Section 4(b)(ii) as if the Executive had been terminated without cause, plus any legal fees and related costs and
    expenses expended in connection with such legal proceedings.
	 	 	 
	 	(ii)	Non-renewal:
    Termination Without Cause: Resignation for Good Reason. The Company reserves the right to terminate the Executive’s
    employment without Cause at any time prior to the expiry of the Employment Term, or to decline to renew the Employment Term.
    Additionally, a resignation for Good Reason in accordance with Section 4(c)(i) below shall be deemed to constitute a termination
    without Cause by the Company within the meaning of this Section 4(b)(ii).
	 	 	 
	 	 	In
    the event that: (a) the Company declines to renew the Employment Term; or (b) the Executive is terminated by the Company without
    Cause, or (c) the Executive resigns for Good Reason in accordance with Section 4(c)(i) below, in addition to those entitlements
    and obligations set out in Section 4{f), the Executive shall be entitled to the following:

 

    	 	 	 Page 4 to 19

     

    

 

	 	(A)	The
    Executive shall be entitled a severance payment equal to Eighteen (18) months’ Compensation (as defined below), plus
    One (1) additional month’s Compensation for every full year of employment completed after the second anniversary of
    the date that the Executive Consultant Agreement was executed with Scythian Biosciences, Inc., subject to an aggregate cap
    of Twenty-four (24) months’ Compensation, which severance shall be deemed to be inclusive of, and is not in addition
    to, any applicable statutorily prescribed notice or severance to which the Executive is then entitled.
	 	 	 
	 	(B)	For
    these purposes, “Compensation” for each month shall mean the sum of:

 

	 	(1)	1/12‘h
    of the Executive’s Base Salary in effect as of the Termination Date;
	 	 	 
	 	(2)	1/12‘h
    of the Executive’s target Annual Bonus then in effect as of the Termination Date; and,
	 	 	 
	 	(3)	the
    total of all monthly allowances then in effect as of the Termination Date,
	 	 	 
	 	each
    as determined in accordance with Schedule 1.

 

The
foregoing shall be provided to the Executive by the Company within Thirty (30) days of the Termination Date, provided that, in
consideration of and as a condition precedent to receiving any entitlement under this Section 4(b)(ii) that exceeds any minimum
applicable statutorily prescribed termination-related entitlements, within Two (2) weeks after the Termination Date the Executive
signs and delivers to the Company, and does not revoke, a release of claims in favour of the Company and its subsidiaries or affiliates
that is based on the standard form release of claims then in use by the Company, substantially in the form attached as Schedule
3

 

		(c)	Termination
                                         by Executive

 

	 	(i)	Executive’s
    Resignation for Good Reason. If the Executive wishes to resign for Good Reason, then:

 

	 	(A)	Within
    Fourteen (14) days following the occurrence of a Good Reason Event, the Executive must provide written notice to the Company
    specifying both the basis of such breach and expressly stating what remedial action is required to cure such
    breach.
	 	 	 
	 	(B)	If,
    within Thirty (30) days after the Company’s receipt of such written notice, the Company cures such alleged breach, then
    such occurrence will cease to constitute a Good Reason Event.
	 	 	 
	 	(C)	If,
    within Thirty (30) days after the Company’s receipt of such written notice, the Company fails to cure such alleged breach,
    then the Executive’s resignation for Good Reason will take effect on the first business day following the expiry of
    such cure period, on which date the Executive’s employment shall be deemed to have been terminated without Cause within
    the meaning of Section 4(b)(ii).

 

    	 	 	 Page 5 to 19

     

    

 

	 	(ii)	Executive’s
    Resignation without Good Reason. If the Executive wishes to resign without Good Reason, then the Executive must provide
    no less than Four (4) weeks’ written notice to the Company. The Company reserves the right to waive any resignation
    notice in excess of Four (4) weeks. Upon resignation without Good Reason, Section 4(f) shall apply.

 

	 	(d)	Termination
    upon Death or Disability. This Agreement shall automatically terminate in the event of the Executive’s death or
    Permanent Disability (as defined below). In such event, in addition to those entitlements and obligations set out in Section
    4(f), the Company shall continue to pay the Executive or his estate or designated beneficiary (as applicable) the Executive’s
    Base Salary for a period ending Twelve (12) months from the Termination Date, and shall continue to provide either (as applicable
    and as in effect) the health insurance allowance or any then-existing health insurance at the Company’s expense for
    the Executive and his family (provided an appropriate COBRA election is made) for the same 12-month period, provided that,
    in consideration of and as a condition precedent to receiving any entitlement under this Section 4(d) that exceeds any minimum
    applicable statutorily prescribed termination-related entitlements, the Executive or his representative (or, in the event
    of his death, his estate executor or other duly appointed legal representative) signs and delivers to the Company, and does
    not revoke, a release of claims in favour of the Company and its subsidiaries and affiliates that is based on the standard
    form release of claims then in use by the Company, substantially in the form attached as Schedule 3.
	 	 	 
	 	 	For
    these purposes, “Permanent Disability” is defined as physical or mental incapacity resulting in the absence from
    or inability to properly perform his duties hereunder (as determined by the Company) for One Hundred Eighty (180) consecutive
    days. Returns to work for periods of less than One (1) week shall not toll the passing of the time required to establish Permanent
    Disability hereunder.
	 	 	 
	 	(e)	Effect
    of Termination on Lock-Up Agreement. Upon any termination of employment pursuant to Sections 4(b), 4(c)(i) or 4(d), in
    the event that Executive has agreed to a lock-up restriction on the sale of his stock and options, such restriction shall
    be immediately released as of the Termination
    Date, provided always that any restrictions on the sale of the Executive’s stock and options imposed by any Exchange
    or by application of other law shall remain in effect.

 

    	 	 	 Page 6 to 19

     

    

 

	 	(f)	Termination
    - General. Upon any termination for any reason whatsoever of the Executive’s employment:

 

	 	(i)	If
    applicable, Executive will be entitled to exercise his COBRA rights to continue benefits covered by COBRA.
	 	 	 
	 	(ii)	Any
    accumulated unused vacation pay, and Base Salary and Annual Bonus monies that accrued prior to the Termination Date but was
    not paid will be paid within 30 days of the trigger date.
	 	 	 
	 	(iii)	With
    respect to the Annual Bonus:

 

	 	(A)	The
    Executive forfeits any entitlement to receive any Annual Bonus for any Bonus Period (as defined in Schedule 1 to this Agreement)
    commencing after the Termination Date, and the Executive will not be entitled to any compensation for any such accrued amounts
    (except as provided in Section 4(b)(ii)).
	 	 	 
	 	(B)	If
    the Executive is terminated for Cause, the Executive further forfeits any entitlement to receive any future but unaccrued
    Annual Bonus and the Executive will not be entitled to any compensation for any such forfeited amounts (but for greater clarity,
    any Annual Bonus accrued before the Termination Date remains payable).
	 	 	 
	 	(C)	Subject
    to Sections 4(a)(iii)(A) and 4(a)(iii)(B) above, any accrued but unpaid Annual Bonus will be calculated and, if owing, paid
    at the usual time in accordance with the Schedule 1 to this Agreement, provided that the amount payable will be pro rated
    based on the portion of such Bonus Period during which Executive is employed up to and including the Termination Date.

 

	 	(iv)	Entitlement
    to use of any Company-supplied equipment, vehicle or device and to any form of allowance, as applicable, will end on the Termination
    Date.
	 	 	 
	 	(v)	The
    Executive will comply with his return of property obligations under Section 5(c) below and will also immediately deliver or
    cause to be delivered to the Company a complete and up-to-date list of all work-related passwords required for purposes of
    performing his work responsibilities, including those he set up himself and those provided to him by the Company.

 

    	 	 	 Page 7 to 19

     

    

 

	 	(vi)	The
    Executive will immediately take all necessary steps to ensure that all electronically-stored Confidential Information or Inventions
    (each as defined in Section 5 below) have been transferred to the Company from (and fully deleted from) his personal/household
    cell phone, computer/lap-top or similar devices and systems, and that any Company-licensed software has been “wiped”
    from such personal/household devices and systems.
	 	 	 
	 	(vii)	Subject
    to compliance with the Company’s usual expense reimbursement policies, and presentation of proper receipts and expense
    reports, the Executive will receive reimbursement of any authorized expenses properly incurred as of the Termination Date
    (and for greater clarity, he will not be entitled to be reimbursed for any expenses incurred after the Termination Date, unless
    preapproved by a member of the Audit Committee).
	 	 	 
	 	(viii)	Where
    applicable and subject to any different entitlements under any applicable shareholders’ agreement, upon request from
    the Company the Executive will forthwith resign in writing as an officer or director of the Company or any of its subsidiaries
    or affiliates, effective upon the Termination Date. Such resignation will be without prejudice to any rights of the Executive
    under this Agreement.
	 	 	 
	 	(ix)	Where
    applicable, any entitlements regarding profit sharing and retirement savings plans will be governed by the terms of the relevant
    plan(s);
	 	 	 
	 	(x)	Where
    applicable, and subject always to Schedule 2 to this Agreement, any entitlements regarding: (i) any stock options or other
    equity granted to the Executive pursuant to the Company’s Stock Option Plan will be governed by the terms of the relevant
    award agreement(s); and (ii) any shares of the Company owned or controlled by the Executive as of the Termination Date will
    be governed by the relevant subscription agreement(s).
	 	 	 
	 	(xi)	Where
    applicable, any entitlement to other equity based or other discretionary compensation plan, such as a stock bonus or deferred
    share plan, will be governed by the terms of the relevant plan(s) and award agreement(s).
	 	 	 
	 	(xii)	Except
    as otherwise expressly set out above in this Section 4, or as otherwise strictly prescribed by applicable statutes, the Executive
    shall not be entitled to any further notice or severance or compensation/damages in lieu of notice or any other compensation
    or benefits or entitlements of any nature whatsoever.

 

    	 	 	 Page 8 to 19

     

    

 

	5.	Confidentiality
                                         and Ownership of Company Property

 

		(a)	Confidential
                                         Information

 

	 	(i)	“Confidential
    Information” means information that the Company has or will develop, acquire, create, compile, discover or own, that
    has value in or to the Company’s business which is not generally known and which the Company wishes to maintain as confidential,
    or which belongs to a third party and is subject to a duty on the Company’s part to maintain its confidentiality. Confidential
    Information includes not only information disclosed by the Company to the Executive, but also information learned or developed
    by the Executive during the course of his employment by the Company in connection with performing his job functions, as well
    as also all information of which the unauthorized disclosure could be detrimental to the interests of the Company, whether
    or not such information is identified as Confidential Information. Confidential information includes but is not limited to
    anything related to the procurement of the necessary approvals to operate the Company and portions thereof, strategies and
    plans, contracts, financial information, professional fee information, salary information, lists, payor and vendor lists,
    cost and profit information, record keeping practices, policies and procedures, operational matters and practices, information,
    development and research work, marketing programs, plans, proposals, applications, accompaniments to applications, narrative
    descriptions, manuals and materials, nutrient formulas, soil formulas, chemical formulas, cultivation processes, know-how,
    other trade secrets, trademarks, copyrights, patents, marijuana plant genetics and strains, business and financial records,
    clinical and non-clinical trial results, data received from institutions, customer lists and contractor list and other information
    owned and/or created by or for the Company that would constitute a trade secret and/or confidential information under New
    York Law or the Federal Trade Secrets Act, 18 U.S.C. § 1836 et seq. Notwithstanding the foregoing, the term “Confidential
    Information” does not include, and Executive shall not be restricted during or after his employment with the Company
    from using any information, even if otherwise designated as “Confidential Information”: (i) which Executive learned
    of other than in the course of his employment with the Company; (ii) which is obtainable from sources outside of the Company,
    without breaching any contractual or other obligations; or (iii) which otherwise exists in the public domain.
	 	 	 
	 	(ii)	The
    Executive agrees that during his employment with the Company, he will not improperly use, disclose, or induce the Company
    to use any proprietary information or trade secrets of any former employer or other person or entity with which the Executive
    has an obligation to keep in confidence, and further agrees that the
	 	 	 
	 	 	Executive
    will not bring onto the Company’s premises or transfer onto the Company’s technology systems any unpublished document,
    proprietary information, or trade secrets belonging to any such third Party unless disclosure to, and use by, the Company
    has been consented to in writing by such third Party.
	 	 	 
	 	(iii)	The
    Executive shall not, either during his employment by the Company or at any time after termination for any reason whatsoever
    of such employment, impart or disclose any Confidential Information to any person, firm or entity other than the Company,
    or use any of such Confidential Information, directly or indirectly, for his own benefit or for the benefit of any person,
    firm or entity other than the Company. The Executive hereby acknowledges that the items included within the definition of
    Confidential Information are valuable assets of the Company and that the Company has a legitimate business interest in protecting
    such Confidential Information.

 

    	 	 	 Page 9 to 19

     

    

 

		(b)	Ownership
                                         of Inventions

 

	 	(i)	The
    Executive agrees that all right, title, and interest in and to any and all copyrightable material, notes, records, drawings,
    designs, inventions, improvements, developments, discoveries and trade secrets conceived, discovered, authored, invented,
    developed or reduced to practice by the Executive, solely or in collaboration with others, during the course of and the term
    of his employment with the Company (including during his off-duty hours), or with the use of Company’s equipment, supplies,
    facilities, or Confidential Information, and any copyrights, patents, trade secrets, mask work rights or other intellectual
    property rights relating to the foregoing (collectively, “Inventions”), are the sole property of the Company.
    The Executive also agrees to promptly make full written disclosure to the Company of any Inventions, and to deliver and assign
    and hereby irrevocably assigns fully to the Company all of his right, title and interest in and to Inventions. The Executive
    further acknowledge that all original works of authorship that are made by the Executive (solely or jointly with others) within
    the scope of and during the period of my employment with the Company and that are protectable by copyright are “works
    made for hire,” as that term is defined in the United States Copyright Act and are “works made in the course of
    employment”, as that term is defined in the Copyright Act of Canada. The Executive understands and agrees that the decision
    whether or not to commercialize or market any Invention is within the Company’s sole discretion and for the Company’s
    sole benefit, and that no royalty or other consideration will be due to the Executive as a result of the Company’s efforts
    to commercialize or market any such Invention. The Executive will not incorporate any invention, improvement, development,
    concept, discovery, work of authorship or other proprietary information owned by any third Party into any Invention without
    the Company’s prior written permission.
	 	 	 
	 	(ii)	Any
    assignment to the Company of Inventions includes all rights of attribution, paternity, integrity, modification, disclosure
    and withdrawal, and any other rights throughout the world that may be known as or referred to as “moral rights,”
    “artist’s rights,” “droit moral,” or the like (collectively, “Moral Rights”). To
    the extent that Moral Rights cannot be assigned under applicable law, the Executive hereby irrevocably waives and agrees not
    to enforce any and all Moral Rights, including, without limitation, any limitation on subsequent modification, to the extent
    permitted under applicable law.
	 	 	 
	 	(iii)	The
    Executive agrees to keep and maintain adequate, current, accurate, and authentic written records of all Inventions made by
    the Executive (solely or jointly with others) during the term of my employment with the Company and such records are and will
    be available to and remain the sole property of the Company at all times. The Executive further agrees to assist the Company,
    or its designee, at the Company’s expense, in every proper way to secure the Company’s rights in the Inventions
    in any and all countries, including the disclosure to the Company of all pertinent information and data with respect thereto,
    the execution of all applications, specifications, oaths, assignments, and all other instruments that the Company shall deem
    proper or necessary in order to apply for, register, obtain, maintain, defend, and enforce such rights, and in order to deliver,
    assign and convey to the Company, its successors, assigns, and nominees the sole and exclusive rights, title, and interest
    in and to all Inventions, and testifying in a suit or other proceeding relating to such Inventions.
	 	 	 
	 	(iv)	The
    Executive understands that the provisions of this Agreement requiring assignment of Inventions to the Company do not apply
    to any Invention that the Executive has developed entirely on his own time without using the Company’s equipment, supplies,
    facilities, trade secret information or Confidential Information (an “Other Invention”) except for those Other
    Inventions that either (i) relate to the Company’s business, including actual or anticipated research or development
    of the Company or (ii) result from or relate to any work that he performed for the Company or to any Confidential Information
    or Inventions. The Executive agrees that he will not incorporate, or permit to be incorporated, any Other Invention owned
    by him or in which he has an interest into a Company product, process or service without the Company’s prior written
    consent. Notwithstanding the foregoing sentence, if he incorporates into a Company product, process or service an Other Invention
    owned by him or in which he has an interest, the Executive hereby grants to the Company a nonexclusive, royalty free, fully
    paid-up, irrevocable, perpetual, transferable, sublicensable, worldwide license to reproduce, make derivative works of, distribute,
    perform, display, import, make, have made, modify, use, sell, offer to sell, and exploit in any other way such Other Invention
    as part of or in connection with such product, process or service, and to practice any method related thereto.

 

    	 	 	 Page 10 to 19

     

    

 

	 	(c)	Company
    Property: Return of Company Property All materials relating to the business and affairs of the Company and any of its
    subsidiaries or affiliates including, without limitation, all manuals, documents, reports, equipment, working materials and
    lists of customers prepared by the Company or by the Executive in the course of employment are for the benefit of the Company
    and are and will remain the property of the Company. The Executive will surrender and deliver to the Company all such materials,
    data, information and property, and anything containing or constituting Confidential Information or Inventions, upon the termination
    for any reason whatsoever of the Executive’s employment, or at an earlier time on the request of the Company.

 

	6.	Policies

 

The
Executive will comply with all the Company’s policies as may be established and amended from time to time. The Executive
acknowledges having received and reviewed a copy of the company handbook which describes the Company’s policies currently
in effect.

 

	7.	General

 

	 	(a)	Independent
    Legal Advice. The Executive acknowledges that he has read and understood the terms and conditions of this Agreement and
    acknowledges and agrees that he has had the opportunity to seek, and was neither prevented nor discouraged by the Company
    from seeking, any independent legal advice which he considered necessary prior to the execution and delivery of this Agreement
    and that, in the event that he did not avail himself of that opportunity prior to signing this Agreement, he did so voluntarily
    without any undue pressure, and agrees that his failure to obtain independent legal advice will not be used by him as a defence
    to the enforcement of his obligations under this Agreement.
	 	 	 
	 	(b)	Notices.
    All notices and other communications to be made hereunder shall be in writing and shall be deemed to have been given when
    the same are: (a) (i) personally delivered; (ii) mailed, registered or certified mail, first class postage prepaid rectum
    receipt requested; or (iii) delivered by a reputable private overnight courier service utilizing a written receipt or other
    written proof of delivery, to the applicable Party at the address set forth above; and (b) sent by email or other functionally
    equivalent electronic means, delivery receipt requested. In the case of Executive, notices shall be addressed to Executive
    at the home address (in the case of mailed or couriered notices) and the personal email address (in the case of electronic
    delivery) that he most recently communicated to the Company in writing. Any Party refusing delivery of a notice shall be charged
    with knowledge of its contents.

 

    	 	 	 Page 11 to 19

     

    

 

	 	(c)	Successors
    and Assigns. The Executive acknowledges that the Executive’s services are unique and personal. The Executive may
    not assign the Executive’s rights or delegate the Executive’s duties or obligations under this Agreement. This
    Agreement shall be binding upon and inure to the benefit of the Company and its respective successors and assigns by merger,
    consolidation, transfer of business and properties or otherwise, and shall be binding on and inure to the benefit of the Executive
    and his heirs and legal representatives.
	 	 	 
	 	(d)	Survival:
    Enforceability. Notwithstanding the termination for any reason whatsoever of this Agreement or of the Executive’s
    employment hereunder, the provisions of Sections 4(b)(ii), 4(f), Section 5 and this Section 7 shall survive and remain enforceable.
    The Executive agrees and acknowledges that the existence of any claim or cause of action the Executive may have or assert
    against the Company or its subsidiaries or affiliates, whether based on this Agreement or otherwise, will not constitute a
    defense to the enforcement of his obligations under Section 4(f) and Section 5.
	 	 	 
	 	(e)	Severability.
    In the event any one or more of the provisions of this Agreement shall be held to be, in whole or in part, invalid, illegal
    or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect the remainder of such provision
    or other provisions hereof, and this Agreement shall be construed as if such invalid, illegal or unenforceable provision (or
    part provision) never had been contained herein.
	 	 	 
	 	(f)	Injunctive
    Relief. The Executive recognizes and agrees that any material violation of the provisions of Section 5 of this Agreement
    would cause such damage or injury to the Company as would be irreparable the exact amount of damage would be impossible to
    ascertain; therefore, the Executive agrees that notwithstanding anything to the contrary contained in this Agreement, the
    Company shall be entitled to seek injunctive relief from a court of competent jurisdiction in the jurisdiction and venue in
    which Executive resides to seek an injunction against such violations or threatened violations. Such right to seek an injunction
    shall be cumulative and in addition to, and not in limitation of, any other rights and remedies by the Company may have in
    equity or at law.
	 	 	 
	 	(g)	Governing
    Law, Forum Selection. This Agreement shall be construed in accordance with the laws of the State of New York, United States,
    exclusive of any choice of law principles. In the event any dispute arises between the Parties relative to this Agreement,
    then the dispute shall be litigated in any federal or state court of competent jurisdiction in the City of New York, State
    of New York, United States and both Parties agree to personal jurisdiction in such courts.

 

    	 	 	 Page 12 to 19

     

    

 

	 	(h)	Currency.
    All currency amounts referenced in this Agreement are in Canadian dollars (gross) unless otherwise expressly stated and all
    payments made to the Executive under this Agreement or in respect of Executive’s employment shall be made subject to
    all applicable statutory deductions and withholdings.
	 	 	 
	 	(i)	Entire
    Agreement: Amendments. This Agreement (inclusive of the attached Schedules hereby incorporated by reference), contains
    the entire understanding and agreement of the Parties hereto with respect to the matters contained herein, and may not be
    amended or supplemented at any time unless by writing, executed by each of the said Parties. Any agreement or understanding,
    written or otherwise, prior to the effective date of this Agreement between the Executive and the Company relating to the
    employment of the Executive is hereby terminated and discharged. Notwithstanding anything to the contrary in this Agreement,
    the parties recognize that the obligations under Sections 5.1, 5.4, 5.5 and 5.6 of the Executive Consultant Agreement which
    by their nature are intended to survive the termination of such agreement shall remain in full force and effect and enforceable
    in accordance with their terms. Moreover, all compensation vested in Executive and/or already paid to Executive under the
    Executive Consulting Agreement shall remain due and owing, including securities earned, unless expressly waived in writing
	 	 	 
	 	U)	Indemnification
    and Insurance. The Company shall save, defend, indemnify and hold harmless the Executive against all losses (including
    all settlements or judgments), claims, expenses, or other liabilities of any nature arising from or relating to: (a) Executive’s
    employment with the Company or any subsidiary or affiliate of the Company; (b) the conduct of Executive’s job duties
    for the Company or any subsidiary or affiliate; (c) claims asserted against Executive by virtue of his legal capacity as an
    officer, director, consultant, or agent of the Company or any of its subsidiaries or affiliates; (d) the patents assigned
    by Executive to the Company, or its subsidiaries or affiliates; (e) any claim of product liability relating to the drug therapies
    being developed by the Company; (f) any guarantee or alleged joint liability of or for any obligation of the Company or any
    of its subsidiaries or affiliates which may be asserted against Executive. Notwithstanding the foregoing, this indemnity obligation
    shall not apply in respect of any claims that arise from or relate to conduct by the Executive in respect of which the Executive:

 

	 	(1)	did
    not act honestly and in good faith with a view to the best interests of the Company; or,
	 	 	 
	 	(2)	in
    the case of a criminal or administrative action or proceeding that is enforced by a monetary penalty where the Executive did
    not have reasonable grounds for believing that his conduct was lawful.

 

    	 	 	 Page 13 to 19

     

    

 

	 	Without
    limiting the foregoing, the Executive shall be entitled to payment of all reasonable costs and expenses including attorneys’
    fees incurred in the defense of any action or proceeding arising out of his employment and any settlement or judgment. The
    Executive shall be entitled to counsel selected by the Company subject to the Executive’s consent, not to be unreasonably
    withheld. The Company shall pay any counsel so retained for Executive for all such fees and costs incurred on the terms negotiated
    with such counsel. The Company shall pay any settlement or judgment involving or entered against Executive within the time
    provided by any settlement agreement or by the Court in which any judgment is entered. The Company also agrees to obtain,
    on commercially reasonable terms, such D&O insurance, general liability insurance and other insurance as a prudent comparably
    sized company would obtain to protect against liability for any potential claim against Executive.

 

	 	(k)	Acknowledgement:
    Waiver. The Executive acknowledges that the grant of stock options provided for in Schedule 2 to this Agreement constitutes
    actual, valuable fresh consideration in exchange for signing this Agreement and the Executive hereby waives irrevocably any
    right he may have to assert that this Agreement should be invalid, void or voidable, in whole or in part, for lack of consideration.
	 	 	 
	 	(I)	Counterparts.
    This Agreement may be executed and delivered by the Parties in one or more counterparts, each of which when so executed
    and delivered will be an original, and those counterparts will together constitute one and the same instrument.
	 	 	 
	 	(m)
    	Execution.
    Execution and delivery of a facsimile or other functionally equivalent means of electronic execution and transmission
    of this Agreement will constitute, for purposes of this Agreement, delivery of an executed original and will be binding upon
    the Party whose signature appears on the transmitted copy. Any Party so executing this Agreement undertakes to originally-execute
    and deliver to the other Parties a copy of this Agreement as soon as possible after such electronic execution and transmission.

 

    	 	 	 Page 14 to 19

     

    

 

IN
WITNESS WHEREOF, the Parties hereto have executed this Agreement or caused their duly authorized officers to execute this Agreement
on date set forth above.

 

	 	SCYTHIAN
    BIOSCIENCES, CORP.
		 
	 	
	 	Michael
    Petter, Director
		 
	 	
	 	Jonathan
    Gilbert

 

    	 	 	 Page 15 to 19

     

    

 

SCHEDULE
1

REMUNERATION
AND FRINGE BENEFITS

 

	1.	Base
    Salary. As compensation for the services to be rendered by the Executive hereunder, the Company shall pay the Executive
    an annual base salary (the “Base Salary) as follows:

 

	 	(a)	During
    the first year of the Initial Term, Executive shall receive a Base Salary equal to Two Hundred and Fifty Thousand Dollars
    (CDN$250,000) per annum.
	 	 	 
	 	(b)	During
    each subsequent year of the Initial Term, the Base Salary shall increase by an additional Twenty Thousand Dollars (CON $25,000).
	 	 	 
	 	(c)	The
    salary for any Renewal Term(s) shall be agreed upon by the Parties but shall not be less than the Base Salary for the immediately
    previous year of the Employment Term plus an additional (CON $10,000).
	 	 	 
	 	(d)	The
    Company shall make such payments to the Executive by wire to the bank account information provided by Executive to the Company.
	 	 	 
	 	(e)	In
    the event that the exchange rate between the Canadian dollar and the United State dollar shall change such that the Canadian
    dollar shall become worth less than 0.757 U.S. dollars, the then in effect Base Salary shall be increased such that it shall
    be a minimum of 0.757 U.S dollars for each CON of the Base Salary level. By way of example, if the exchange rate shall become
    0.70 U.S. dollars per Canadian dollar, the Base Salary for year one would be increased to (CDN$180,000 x 757/700 = CDN$194,657).
    This conversion increase shall only apply during any bi weekly pay period in which this decrease in the value of the Canadian
    dollar has occurred and conversion shall be made based upon the lowest US dollar conversion amount applicable during that
    pay period.

 

	2.	Vacation
    Time and Vacation Pay
	 	 
	 	The
    Executive will be entitled to Four (4) weeks’ vacation per year to be taken at a time or times acceptable to the Company,
    and shall increase at the rate of One (1) week per year annually, to a maximum of Six (6) weeks per year. Accumulated but
    unused vacation time may be carried over from year to year. In the event that any such unused vacation time exists at the
    time of the Executive’s Termination Date, the Executive shall be compensated for such unused vacation time within 30
    days of termination.

 

    	 	 	 Page 16 to 19

     

    

 

	3.	Bonus
	 	 
	 	The
    Executive shall be paid an annual bonus (the “Annual Bonus”) equal to the greater of (a) 0.5% of
    the Company’s gross revenue for each calendar year or portion thereof during which Executive is employed up to and including
    the Termination Date, or (b) 15% of the Executive’s annual salary for the concluding year. Such bonus shall accrue on
    an ongoing basis but shall be payable within Thirty (30) days following the conclusion of each twelve month anniversary of
    the commencement of this Agreement (each such concluded twelve month period, a “Bonus Period”), subject always
    to Section 4(f) of the Agreement.
	 	 
	 	The
    Executive shall additionally be eligible for a discretionary bonus to be determined by the Company’s Compensation Committee
    which may consist of both cash and stock or other securities of the Company. For greater clarity, the Executive acknowledges
    that discretionary bonus is not guaranteed and: (i) whether any discretionary bonus will be awarded, and if so, the amount
    awarded, are both fully discretionary to the Compensation Committee; and (ii) the award of any discretionary bonus in respect
    of any year does not in any manner entitle the Executive to receive a similar award, or any award, in any other year, nor
    does it entitle the Executive to claim any compensation in lieu of such award.
	 	 
	 	The
    Executive shall be awarded a bonus of CDN$50,000 upon (a) any new drug R&D program instituted by the Company; and (b)
    the grant of an IND by the U.S. FDA in connection with each drug development project, provided that such grant occurs on or
    before the Termination Date. Such sum shall be paid within 30 days of the triggering event.
	 	 
	 	The
    Executive shall be awarded an bonus of CDN$100,000 upon the grant of an NOA by the U.S. FDA in connection with each drug development
    project, provided that such grant occurs on or before the Termination Date. Such sum shall be paid within 30 days of the triggering
    event.
	 	 
	4.	Benefits
    and Allowances
	 	 
	 	The
    Executive shall be eligible to participate in the Company’s health insurance plan (in the event that the Company adopts
    any such plan) with individual and family coverage at the Company’s expense, subject to the terms of that plan as amended
    from time to time, on the same basis as the Company’s other senior executives. Or in the case the Company does not adopt
    a health insurance plan, the Executive shall be paid a health insurance allowance of CDN$1,000 per month, entitlement to which
    ceases on the Termination Date.
	 	 
	 	The
    Executive shall be entitled to participate in the Company’s profit sharing and retirement savings plans (in the event
    that the Company adopts any such plan(s)), subject to the terms of such plans as amended from time to time, on the same basis
    as the Company’s other senior executives. Entitlement to participation ceases on the Termination Date. The Executive
    shall be paid both a cell phone allowance of CDN$130 per month and an automobile and parking allowance of CDN$500 per month,
    entitlement to which ceases on the Termination Date.
	 	 
	5.	Expenses
	 	 
	 	The
    Company shall issue the Executive an American Express and any other appropriate corporate credit card(s) to be used by the
    Executive for all reasonable expenses properly incurred in the performance of his duties. The Executive will be reimbursed
    for all other reasonable out-of-pocket expenses properly incurred in the fulfillment of his duties as set out in this Agreement,
    including travel and entertainment, upon prior approval and presentation of that documentation as the Company may reasonably
    request and in accordance with the Company’s standard expense and reimbursement policies.

 

    	 	 	 Page 17 to 19

     

    

 

SCHEDULE
3

FORM
OF RELEASE AGREEMENT

 

GENERAL
RELEASE

 

KNOW
ALL MEN BY THESE PRESENTS:

 

THAT,
JONATHAN GILBERT, (collectively “First Party”), for and in consideration of the sum of Ten ($10.00) Dollars and/or
other valuable considerations, received from or on behalf of SCYTHIAN BIOSCIENCES, CORP., (collectively “Second Party”),
the receipt whereof is hereby acknowledged.

 

(Wherever
used herein the terms “First Party” and “Second Party” shall include singular and plural, heirs, legal
representatives, and assigns of individuals, and the successors and assigns of corporations, wherever the context so admits or
requires.)

 

With
the exception of the matters identified below as expressly excluded from this General Release (collectively the “Excluded
Matters”), First Party HEREBY remises, releases, acquits, satisfies, and forever discharges the said Second Party, of and
from all other manner of action and actions, cause and causes of action, suits, debts, dues, sums of money, accounts, reckonings,
bonds, bills, specialties, covenants, contracts, controversies, agreements, promises, variances, trespasses, damages, judgments,
executions, claims and demands whatsoever, in law or in equity, which said First Party ever had, now has, or which any personal
representative, successor, heir or assign of said First Party, hereafter can, shall or may have, against said Second Party, for,
upon or by reason of any and all injuries and damages of any and every kind, to both person and property, and also any and all
injuries and damages that may develop in the future, as a result of or in any way relating to First Parties employment
with Second Party. This release shall expressly not include any claims by First Party against Second Party arising out of a breach
of the employment agreement entered into First Party and Second Party. Nothing herein shall act to in any way release the rights
of the First Party in connection with any vested securities that he owns in the Second Party or any affiliate thereof, as well
as any earned or vested but otherwise unpaid compensation.

 

REMAINDER
OF PAGE LEFT INTENTIONALLY BLANK

 

    	 	 	 Page 18 to 19

     

    

 

IN
WITNESS WHEREOF, I have hereunto set my hand and seal this_ day of June, 2017.

 

Signed,
sealed and delivered in the

 

presence
of:

 

		 	
	 	 	Jonathan
    Gilbert

 

STATE
OF FLORIDA

 

)
ss:

 

COUNTY
OF BROWARD

 

I
HEREBY CERTIFY that on this day, before me, an officer duly authorized in the State aforesaid and in the County aforesaid to take
acknowledgments, personally appeared Jonathan Gilbert to me known to be the person described herein, or who provided _____________________as
identification, and who executed the foregoing instrument and he acknowledged before me that he executed the same.

 

WITNESS
my hand and official seal in the County and State last aforesaid this ________day of ___________________, 2016.

 

My
Commission Expires:

 

NOTARY
PUBLIC, STATE OF FLORIDA

 

    	 	 	 Page 19 to 19EMPLOYMENT
AGREEMENT

 

THIS
EMPLOYMENT AGREEMENT (the “Agreement”), dated and effective as of the _______day of ______2017 (the “Effective
Date”), is entered by and between Scythian Biosciences, Corp., a body corporate formed under the Business Corporations
Act of Canada (the “Company”), with a registered office located at ___________and David Schrader (the “Executive”)
having an address at 411 East 53rd Street, New York, NY 10022. The Company and the Executive may hereinafter be referred
to individually as a “Party” or collectively as the “Parties”.

 

WITNESSETH:

 

WHEREAS,
the Company desires to procure the services of the Executive as its Chief Operating Officer, and the Executive desires to
provide such services to the Company, all upon the terms and conditions hereinafter set forth; and

 

WHEREAS,
the Company recognizes that the Executive, acting through Haven, Astor & Block, LLC, has provided substantial valuable
services to the Company and/or its affiliates, and has specific expertise relating to the Company’s business; and

 

WHEREAS,
the Parties agree that this Agreement is intended to supersede the Executive Consultant Agreement made between the Executive
acting through Haven, Astor & Block, LLC and Scythian Biosciences, Inc. dated effective as of April 1, 2015 (“Executive
Consultant Agreement”), subject only to Section ?(i) hereof;

 

NOW,
THEREFORE, in consideration of the mutual promises contained herein, and for other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, and intending to be legally bound hereby, the Company and the Executive agree
as follows:

 

	1.	Employment

 

The
Company agrees to employ the Executive as the Chief Operating Officer of the Company, and the Executive accepts the employment,
on the terms and conditions hereafter set forth. The employment shall be on a part-time basis with the Executive performing his
duties hereunder primarily at the Company’s New York, NY office or elsewhere at Executive’s discretion. The Executive
will devote such time as shall be required to satisfy the duties of the position, including at the Company’s expense, periodic
visits to research centers conducting the Company’s medical research and such other locations as may be necessary. It is
expressly understood and acknowledged that Executive may have other employment outside of this position, provided always that
the Executive shall refrain from any other employment or involvements which may be harmful to or competitive with the Company,
or would in any way constitute (or could reasonably be perceived to constitute) a conflict of interest with the Executive’s
obligations under this Agreement. It is also agreed that although the Executive is an attorney, licensed in New York, United States,
he is not providing legal services to the Company.

 

    	 	Page
                                         1
                                         of 20

     

    

 

Subject
to the foregoing, during the Employment Term and any Renewal Terms, as those terms are hereinafter defined, when working for Company,
the Executive shall devote his best efforts, knowledge and skill to the Company’s business and affairs. The Executive will
have the rights, duties and obligations customarily associated with the position of Chief Operating Officer of a comparably sized
company, with particular focus on assisting the CEO in coordinating the activities of the Company, including its research and
drug development program, and seeking out new opportunities for the Company for new potential research projects from third persons.
For greater clarity, the Executive is not required to invent new drugs as part of his duties. The Executive will report directly
to the Chief Executive Officer of the Company.

 

	2.	Term
    of Employment; Renewals

 

	 	(a)	Term

 

	 	(i)	The
    employment hereunder shall commence on the date of execution of this agreement (the “Commencement Date”), and
    shall continue until the end of Three (3) years from the Commencement Date, unless sooner terminated pursuant to the terms
    of this Agreement (the “Initial Term”). The “Employment Term” is defined as the Initial Term plus
    any “Renewal Terms” as such term is defined in the next section.
	 	 	 
	 	(ii)	Automatic
    Renewals. After the Initial Term, this Agreement shall automatically renew for subsequent terms of One (1) year (each subsequent
    One (1) year period termed a “Renewal Term”) unless either the Company or the Executive provides to the
    other not less than Thirty (30) days prior to the expiration of the then existing Employment Term written notice of non-renewal.
    The terms and conditions of this Agreement shall continue to apply to each such Renewal Term as part of the Employment Term,
    except as expressly agreed otherwise by the Parties in writing at the time of such renewal.

 

	3.	Compensation

 

The
remuneration of the Executive will be at the fixed rate of salary per annum (“Base Salary”) as set out in Schedule
1 to this Agreement, payable in accordance with the Company’s normal payroll policies in effect from time to time. The Executive
will be entitled to those additional benefits set out in Schedule 1 to this Agreement.

 

The
Executive will also be entitled to participate in the stock option and/or equity stock ownership programs for ownership in the
Company as provided for in Schedule 2 to this Agreement in such amounts as to be reasonably agreed upon between Executive and
the Company once the amount of stock options and/or equity that are available for distribution to Executive is determined.

 

    	 	Page
                                         2
                                         of 20

     

    

 

	4.	Termination

 

In
the event of non-renewal, this Agreement shall automatically terminate at the end of the Employment Term, unless sooner terminated
in accordance with this Section 4.

 

	 	(a)	Definitions.
    For purposes of this Agreement:

 

	 	(i)	“Cause”
    means: (i) the occurrence of an intentional material breach of any material covenant contained in this Agreement by an act
    of gross misconduct by the Executive and the failure to cure such alleged breach after Thirty (30) days prior written
    notice to the Executive specifying both the basis of such breach and expressly stating what remedial action is required
    to cure such breach (provided that the Company reserves the right to suspend the Executive with pay at any time during and
    pending the expiry of such cure period); or (ii) the Executive’s theft or embezzlement from the Company during the Term
    of this Agreement, or (iii) the Executive’s conviction of a felony or indictable offence under the laws of Canada or
    the United States; or (iv) a final order by the Canadian provincial securities commission pertaining to the Executive that
    could reasonably be expected to impair or impede the Executive from performing the functions and duties contemplated by this
    Agreement.
	 	 	 
	 	(ii)	“Change
    of Control” means the occurrence of one of the following events after the Commencement Date: [(1) the acquisition by
    any “Person” (as such term is defined in Section 3(a)(9) of the Securities Exchange Act of 1934 (the “Exchange
    Act”) or Part XX of the Securities Act (Ontario), directly or indirectly, of a sufficient amount of the combined
    voting power of the then outstanding securities entitled to vote generally in the election of directors of the Company that
    such acquisition results in such Person owing in excess of 35% of such combined voting power or (2) any merger, consolidation,
    reorganization, recapitalization, tender or exchange offer or any other transaction with or effecting the Company as a result
    of which a Person owning more than 35% of the combined voting power of the then outstanding securities entitled to vote generally
    in the election of the directors of the Company, or (3) the sale, lease, exchange, transfer or other disposition to any Person
    of all or substantially all of the assets of the Company and its consolidated subsidiaries.
	 	 	 
	 	(iii)	“Good
    Reason Event” means any of the following without the Executive’s written consent of the following events:

 

    	 	Page
                                         3
                                         of 20

     

    

 

	 	(A)	a
    material reduction (of greater than 10% in the aggregate) in his Base Salary, Annual Bonus and/or benefits;
	 	 	 
	 	(B)	a
    material diminution of his duties, responsibilities or reporting responsibility as Chief Operating Officer of the Company,;
	 	 	 
	 	(C)	a
    breach by the Company or any successor of any material provision of this Agreement; or,
	 	 	 
	 	(D)	a
    requirement that Executive spend more than 10% of his business hours at a location other than Executive’s principal
    location in effect prior to the Change of Control.

 

	 	(iv)	“Termination
    Date” means the date designated by the Company as the effective day on which the Executive’s employment ceases
    for any reason whatsoever (regardless of any period of notice or compensation in lieu or severance to which the Executive
    may claim to be or be entitled under statute, contract or otherwise at law).

 

	 	(b)	Termination
    by Company

 

	 	(i)	Termination
    For Cause. The employment of Executive may be terminated by the Company at any time for Cause. To be effective the determination
    of Cause for termination of Executive’s employment hereunder must be made by a majority of the Board of Directors after
    notice to Executive and an opportunity for Executive to be heard by the Board of Directors. Upon termination for Cause, Section
    4(f) shall apply. In the event that the Company terminates Executive for Cause and a final and binding decision is rendered
    in any legal proceeding finding the termination was not properly for Cause, the Executive shall be entitled to all sums set
    forth in Section 4(b)(ii) as if the Executive had been terminated without cause, plus any legal fees and related costs and
    expenses expended in connection with such legal proceedings.
	 	 	 
	 	(ii)	Non-renewal:
    Termination Without Cause: Resignation for Good Reason. The Company reserves the right to terminate the Executive’s
    employment without Cause at any time prior to the expiry of the Employment Term, or to decline to renew the Employment Term.
    Additionally, a resignation for Good Reason in accordance with Section 4(c)(i) below shall be deemed to constitute a termination
    without Cause by the Company within the meaning of this Section 4(b)(ii).
	 	 	 
	 	 	In
    the event that: (a) the Company declines to renew the Employment Term; or (b) the Executive is terminated by the Company without
    Cause, or (c) the Executive resigns for Good Reason in accordance with Section 4(c)(i) below, in addition to those entitlements
    and obligations set out in Section 4(f), the Executive shall be entitled to the following:

 

	 	(A)	The
    Executive shall be entitled a severance payment equal to Eighteen (18) months’ Compensation (as defined below), plus
    One (1) additional month’s Compensation for every full year of employment completed after the second anniversary of
    the date that the Executive Consultant Agreement was executed with Scythian Biosciences, Inc., subject to an aggregate cap
    of Twenty-four (24) months’ Compensation, which severance shall be deemed to be inclusive of, and is not in addition
    to, any applicable statutorily prescribed notice or severance to which the Executive is then entitled.

 

    	 	Page
                                         4
                                         of 20

     

    

 

	 	(B)	For
    these purposes, “Compensation” for each month shall mean the sum of:

 

	 	(1)	1/1ih
    of the Executive’s Base Salary in effect as of the Termination Date;
	 	 	 
	 	(2)	1/1ih
    of the Executive’s target Annual Bonus then in effect as of the Termination Date; and,
	 	 	 
	 	(3)	the
    total of all monthly allowances then in effect as of the Termination Date, each as determined in accordance with Schedule
    1.

 

The
foregoing shall be provided to the Executive by the Company within Thirty (30) days of the Termination Date, provided that, in
consideration of and as a condition precedent to receiving any entitlement under this Section 4(b)(ii) that exceeds any minimum
applicable statutorily prescribed termination-related entitlements, within Two (2) weeks after the Termination Date the Executive
signs and delivers to the Company, and does not revoke, a release of claims in favour of the Company and its subsidiaries or affiliates
that is based on the standard form release of claims then in use by the Company, substantially in the form attached as Schedule
3

 

	 	(c)	Termination
    by Executive

 

	 	(i)	Executive’s
    Resignation for Good Reason. If the Executive wishes to resign for Good Reason, then:

 

	 	(A)	Within
    Fourteen (14) days following the occurrence of a Good Reason Event, the Executive must provide written notice to the Company
    specifying both the basis of such breach and expressly stating what remedial action is required to cure such breach and
    expressly stating what remedial action is required to cure such breach.

 

    	 	Page
                                         5
                                         of 20

     

    

 

	 	(B)	If,
    within Thirty (30) days after the Company’s receipt of such written notice, the Company cures such alleged breach, then
    such occurrence will cease to constitute a Good Reason Event.
	 	 	 
	 	(C)	If,
    within Thirty (30) days after the Company’s receipt of such written notice, the Company fails to cure such alleged breach,
    then the Executive’s resignation for Good Reason will take effect on the first business day following the expiry of
    such cure period, on which date the Executive’s employment shall be deemed to have been terminated without Cause within
    the meaning of Section 4(b)(ii).

 

	 	(ii)	Executive’s
    Resignation without Good Reason. If the Executive wishes to resign without Good Reason, then the Executive must provide
    no less than Four (4) weeks’ written notice to the Company. The Company reserves the right to waive any resignation
    notice in excess of Four (4) weeks. Upon resignation without Good Reason, Section 4(f) shall apply.

 

	 	(d)	Termination
    upon Death or Disability. This Agreement shall automatically terminate in the event of the Executive’s death or
    Permanent Disability (as defined below). In such event, in addition to those entitlements and obligations set out in Section
    4(f), the Company shall continue to pay the Executive or his estate or designated beneficiary (as applicable) the Executive’s
    Base Salary for a period ending Twelve (12) months from the Termination Date, and shall continue to provide either (as applicable
    and as in effect) the health insurance allowance or any then-existing health insurance at the Company’s expense for
    the Executive and his family (provided an appropriate COBRA election is made) for the same 12-month period, provided that,
    in consideration of and as a condition precedent to receiving any entitlement under this Section 4(d) that exceeds any minimum
    applicable statutorily prescribed termination-related entitlements, the Executive or his representative (or, in the event
    of his death, his estate executor or other duly appointed legal representative) signs and delivers to the Company, and does
    not revoke, a release of claims in favour of the Company and its subsidiaries and affiliates that is based on the standard
    form release of claims then in use by the Company, substantially in the form attached as Schedule 3.

 

For
these purposes, “Permanent Disability” is defined as physical or mental incapacity resulting in the absence from or
inability to properly perform his duties hereunder (as determined by the Company) for One Hundred Eighty (180) consecutive days.
Returns to work for periods of less than One (1) week shall not toll the passing of the time required to establish Permanent Disability
hereunder.

 

    	 	Page
                                         6
                                         of 20

     

    

 

	 	(e)	Effect
    of Termination on Lock-Up Agreement. Upon any termination of employment pursuant to Sections 4(b), 4(c)(i) or 4(d), in
    the event that Executive has agreed to a lock-up restriction on the sale of his stock and options, such restriction . shall
    be immediately released as of the Termination Date, provided always that any restrictions on the sale of the Executive’s
    stock and options imposed by any Exchange or by application of other law shall remain in effect.
	 	 	 
	 	(f)	Termination
    - General. Upon any termination for any reason whatsoever of the Executive’s employment:

 

	 	(i)	If
    applicable, Executive will be entitled to exercise his COBRA rights to continue benefits covered by COBRA.
	 	 	 
	 	(ii)	Any
    accumulated unused vacation pay, and Base Salary and Annual Bonus monies that accrued prior to the Termination Date but was
    not paid will be paid within 30 days of the trigger date.
	 	 	 
	 	(iii)	With
    respect to the Annual Bonus:

 

	 	(A)	The
    Executive forfeits any entitlement to receive any Annual Bonus for any Bonus Period (as defined in Schedule 1 to this Agreement)
    commencing after the Termination Date, and the Executive will not be entitled to any compensation for any such accrued amounts
    (except as provided in Section 4(b)(ii)).
	 	 	 
	 	(B)	If
    the Executive is terminated for Cause, the Executive further forfeits any entitlement to receive any future but unaccrued
    Annual Bonus and the Executive will not be entitled to any compensation for any such forfeited amounts (but for greater clarity,
    any Annual Bonus accrued before the Termination Date remains payable).
	 	 	 
	 	(C)	Subject
    to Sections 4(a)(iii)(A) and 4(a)(iii)(B) above, any accrued but unpaid Annual Bonus will be calculated and, if owing, paid
    at the usual time in accordance with the Schedule 1 to this Agreement, provided that the amount payable will be pro rated
    based on the portion of such Bonus Period during which Executive is employed up to and including the Termination Date.

 

	 	(iv)	Entitlement
    to use of any Company-supplied equipment, vehicle or device and to any form of allowance, as applicable, will end on the Termination
    Date.
	 	 	 
	 	(v)	The
    Executive will comply with his return of property obligations under Section 5(c) below and will also immediately deliver or
    cause to be delivered to the Company a complete and up-to-date list of all work-related passwords required for purposes of
    performing his work responsibilities, including those he set up himself and those provided to him by the Company.

 

    	 	Page
                                         7
                                         of 20

     

    

 

	 	(vi)	The
    Executive will immediately take all necessary steps to ensure that all electronically-stored Confidential Information or Inventions
    (each as defined in Section 5 below) have been transferred to the Company from (and fully deleted from) his personal/household
    cell phone, computer/lap-top or similar devices and systems, and that any Company-licensed software has been “wiped”
    from such personal/household devices and systems.
	 	 	 
	 	(vii)	Subject
    to compliance with the Company’s usual expense reimbursement policies, and presentation of proper receipts and expense
    reports, the Executive will receive reimbursement of any authorized expenses properly incurred as of the Termination Date
    (and for greater clarity, he will not be entitled to be reimbursed for any expenses incurred after the Termination Date, unless
    preapproved by the CEO).
	 	 	 
	 	(viii)	Where
    applicable and subject to any different entitlements under any applicable shareholders’ agreement, upon request from
    the Company the Executive will forthwith resign in writing as an officer or director of the Company or any of its subsidiaries
    or affiliates, effective upon the Termination Date. Such resignation will be without prejudice to any rights of the Executive
    under this Agreement.
	 	 	 
	 	(ix)	Where
    applicable, any entitlements regarding profit sharing and retirement savings plans will be governed by the terms of the relevant
    plan(s);
	 	 	 
	 	(x)	Where
    applicable, and subject always to Schedule 2 to this Agreement, any entitlements regarding: (i) any stock options or other
    equity granted to the Executive pursuant to the Company’s Stock Option Plan will be governed by the terms of the relevant
    award agreement(s); and (ii) any shares of the Company owned or controlled by the Executive as of the Termination Date will
    be governed by the relevant subscription agreement(s).
	 	 	 
	 	(xi)	Where
    applicable, any entitlement to other equity based or other discretionary compensation plan, such as a stock bonus or deferred
    share plan, will be governed by the terms of the relevant plan(s) and award agreement(s).
	 	 	 
	 	(xii)	Except
    as otherwise expressly set out above in this Section 4, or as otherwise strictly prescribed by applicable statutes, the Executive
    shall not be entitled to any further notice or severance or compensation/damages in lieu of notice or any other compensation
    or benefits or entitlements of any nature whatsoever.

 

    	 	Page
                                         8
                                         of 20

     

    

 

	5.	Confidentiality
    and Ownership of Company Property

 

	 	(a)	Confidential
    Information

 

	 	(i)	“Confidential
    Information” means information that the Company has or will develop, acquire, create, compile, discover or own, that
    has value in or to the Company’s business which is not generally known and which the Company wishes to maintain as confidential,
    or which belongs to a third party and is subject to a duty on the Company’s part to maintain its confidentiality. Confidential
    Information includes not only information disclosed by the Company to the Executive, but also information learned or developed
    by the Executive during the course of his employment by the Company in connection with performing his job functions, as well
    as also all information of which the unauthorized disclosure could be detrimental to the interests of the Company, whether
    or not such information is identified as Confidential Information. Confidential information includes but is not limited to
    anything related to the procurement of the necessary approvals to operate the Company and portions thereof, strategies and
    plans, contracts, financial information, professional fee information, salary information, lists, payor and vendor lists,
    cost and profit information, record keeping practices, policies and procedures, operational matters and practices, information,
    development and research work, marketing programs, plans, proposals, applications, accompaniments to applications, narrative
    descriptions, manuals and materials, nutrient formulas, soil formulas, chemical formulas, cultivation processes, know-how,
    other trade secrets, trademarks, copyrights, patents, marijuana plant genetics and strains, business and financial records,
    clinical and non-clinical trial results, data received from institutions, customer lists and contractor list and other information
    owned and/or created by or for the Company that would constitute a trade secret and/or confidential information under New
    York Law or the Federal Trade Secrets Act, 18 U.S.C. § 1836 et seq. Notwithstanding the foregoing, the term “Confidential
    Information” does not include, and Executive shall not be restricted during or after his employment with the Company
    from using any information, even if otherwise designated as “Confidential Information”: (i) which Executive learned
    of other than in the course of his employment with the Company: (ii) which is obtainable from sources outside of the Company,
    without breaching any contractual or other obligations; or (iii) which otherwise exists in the public domain.
	 	 	 
	 	(ii)	The
    Executive agrees that during his employment with the Company, he will not improperly use, disclose, or induce the Company
    to use any proprietary information or trade secrets of any former employer or other person or entity with which the Executive
    has an obligation to keep in confidence, and further agrees that the Executive will not bring onto the Company’s premises
    or transfer onto the Company’s technology systems any unpublished document, proprietary information, or trade secrets
    belonging to any such third Party unless disclosure to, and use by, the Company has been consented to in writing by such third
    Party.

 

    	 	Page
                                         9
                                         of 20

     

    

 

	 	(iii)	The
    Executive shall not, either during his employment by the Company or at any time after termination for any reason whatsoever
    of such employment, impart or disclose any Confidential Information to any person, firm or entity other than the Company,
    or use any of such Confidential Information, directly or indirectly, for his own benefit or for the benefit of any person,
    firm or entity other than the Company. The Executive hereby acknowledges that the items included within the definition of
    Confidential Information are valuable assets of the Company and that the Company has a legitimate business interest in protecting
    such Confidential Information.

 

	 	(b)	Ownership
    of Inventions

 

	 	(i)	The
    Executive agrees that all right, title, and interest in and to any and all copyrightable material, notes, records, drawings,
    designs, inventions, improvements, developments, discoveries and trade secrets conceived, discovered, authored, invented,
    developed or reduced to practice by the Executive, solely or in collaboration with others, during the course of and the term
    of his employment with the Company (including during his off-duty hours), or with the use of Company’s equipment, supplies,
    facilities, or Confidential Information, and any copyrights, patents, trade secrets, mask work rights or other intellectual
    property rights relating to the foregoing (collectively, “Inventions”), are the sole property of the Company.
    The Executive also agrees to promptly make full written disclosure to the Company of any Inventions, and to deliver and assign
    and hereby irrevocably assigns fully to the Company all of his right, title and interest in and to Inventions. The Executive
    further acknowledge that all original works of authorship that are made by the Executive (solely or jointly with others) within
    the scope of and during the period of my employment with the Company and that are protectable by copyright are “works
    made for hire,” as that term is defined in the United States Copyright Act and are “works made in the course of
    employment”, as that term is defined in the Copyright Act of Canada. The Executive understands and agrees that the decision
    whether or not to commercialize or market any Invention is within the Company’s sole discretion and for the Company’s
    sole benefit, and that no royalty or other consideration will be due to the Executive as a result of the Company’s efforts
    to commercialize or market any such Invention. The Executive will not incorporate any invention, improvement, development,
    concept, discovery, work of authorship or other proprietary information owned by any third Party into any Invention without
    the Company’s prior written permission.
	 	 	 
	 	(ii)	Any
    assignment to the Company of Inventions includes all rights of attribution, paternity, integrity, modification, disclosure
    and withdrawal, and any other rights throughout the world that may be known as or referred to as “moral rights,”
    “artist’s rights,” “droit moral,” or the like (collectively, “Moral Rights”). To
    the extent that Moral Rights cannot be assigned under applicable law, the Executive hereby irrevocably waives and agrees not
    to enforce any and all Moral Rights, including, without limitation, any limitation on subsequent modification, to the extent
    permitted under applicable law.

 

    	 	Page
                                         10
                                         of 20

     

    

 

	 	(iii)	The
    Executive agrees to keep and maintain adequate, current, accurate, and authentic written records of all Inventions made by
    the Executive (solely or jointly with others) during the term of my employment with the Company and such records are and will
    be available to and remain the sole property of the Company at all times. The Executive further agrees to assist the Company,
    or its designee, at the Company’s expense, in every proper way to secure the Company’s rights in the Inventions
    in any and all countries, including the disclosure to the Company of all pertinent information and data with respect thereto,
    the execution of all applications, specifications, oaths, assignments, and all other instruments that the Company shall deem
    proper or necessary in order to apply for, register, obtain, maintain, defend, and enforce such rights, and in order to deliver,
    assign and convey to the Company, its successors, assigns, and nominees the sole and exclusive rights, title, and interest
    in and to all Inventions, and testifying in a suit or other proceeding relating to such Inventions.
	 	 	 
	 	(iv)	The
    Executive understands that the provisions of this Agreement requiring assignment of Inventions to the Company do not apply
    to any Invention that the Executive has developed entirely on his own time without using the Company’s equipment, supplies,
    facilities, trade secret information or Confidential Information (an “Other Invention”) except for those Other
    Inventions that either (i) relate to the Company’s business, including actual or anticipated research or development
    of the Company or (ii) result from or relate to any work that he performed for the Company or to any Confidential Information
    or Inventions. The Executive agrees that he will not incorporate, or permit to be incorporated, any Other Invention owned
    by him or in which he has an interest into a Company product, process or service without the Company’s prior written
    consent. Notwithstanding the foregoing sentence, if he incorporates into a Company product, process or service an Other Invention
    owned by him or in which he has an interest, the Executive hereby grants to the Company a nonexclusive, royalty free, fully
    paid-up, irrevocable, perpetual, transferable, sublicensable, worldwide license to reproduce, make derivative works of, distribute,
    perform, display, import, make, have made, modify, use, sell, offer to sell, and exploit in any other way such Other Invention
    as part of or in connection with such product, process or service, and to practice any method related thereto.

 

	 	(c)	Company
    Property; Return of Company Property All materials relating to the business and affairs of the Company and any of its
    subsidiaries or affiliates including, without limitation, all manuals, documents, reports, equipment, working materials and
    lists of customers prepared by the Company or by the Executive in the course of employment are for the benefit of the Company
    and are and will remain the property of the Company. The Executive will surrender and deliver to the Company all such materials,
    data, information and property, and anything containing or constituting Confidential Information or Inventions, upon the termination
    for any reason whatsoever of the Executive’s employment, or at an earlier time on the request of the Company.

 

    	 	Page
                                         11
                                         of 20

     

    

 

	6.	Policies

 

The
Executive will comply with all the Company’s policies as may be established and amended from time to time. The Executive
acknowledges having received and reviewed a copy of the company handbook which describes the Company’s policies currently
in effect.

 

	7.	General

 

	 	(a)	Independent
    Legal Advice. The Executive acknowledges that he has read and understood the terms and conditions of this Agreement and
    acknowledges and agrees that he has had the opportunity to seek, and was neither prevented nor discouraged by the Company
    from seeking, any independent legal advice which he considered necessary prior to the execution and delivery of this Agreement
    and that, in the event that he did not avail himself of that opportunity prior to signing this Agreement, he did so voluntarily
    without any undue pressure, and agrees that his failure to obtain independent legal advice will not be used by him as a defence
    to the enforcement of his obligations under this Agreement.
	 	 	 
	 	(b)	Notices.
    All notices and other communications to be made hereunder shall be in writing and shall be deemed to have been given when
    the same are: (a) (i) personally delivered; (ii) mailed, registered or certified mail, first class postage prepaid rectum
    receipt requested; or (iii) delivered by a reputable private overnight courier service utilizing a written receipt or other
    written proof of delivery, to the applicable Party at the address set forth above; and (b) sent by email or other functionally
    equivalent electronic means, delivery receipt requested. In the case of Executive, notices shall be addressed to Executive
    at the home address (in the case of mailed or couriered notices) and the personal email address (in the case of electronic
    delivery) that he most recently communicated to the Company in writing. Any Party refusing delivery of a notice shall be charged
    with knowledge of its contents.

 

    	 	Page
                                         12
                                         of 20

     

    

 

	 	(c)	Successors
    and Assigns. The Executive acknowledges that the Executive’s services are unique and personal. The Executive may
    not assign the Executive’s rights or delegate the Executive’s duties or obligations under this Agreement. This
    Agreement shall be binding upon and inure to the benefit of the Company and its respective successors and assigns by merger,
    consolidation, transfer of business and properties or otherwise, and shall be binding on and inure to the benefit of the Executive
    and his heirs and legal representatives.
	 	 	 
	 	(d)	Survival;
    Enforceability. Notwithstanding the termination for any reason whatsoever of this Agreement or of the Executive’s
    employment hereunder, the provisions of Sections 4(b)(ii), 4(f), Section 5 and this Section 7 shall survive and remain enforceable.
    The Executive agrees and acknowledges that the existence of any claim or cause of action the Executive may have or assert
    against the Company or its subsidiaries or affiliates, whether based on this Agreement or otherwise, will not constitute a
    defense to the enforcement of his obligations under Section 4(f) and Section 5.
	 	 	 
	 	(e)	Severability.
    In the event any one or more of the provisions of this Agreement shall be held to be, in whole or in part, invalid, illegal
    or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect the remainder of such provision
    or other provisions hereof, and this Agreement shall be construed as if such invalid, illegal or unenforceable provision (or
    part provision) never had been contained herein.
	 	 	 
	 	(f)	Injunctive
    Relief. The Executive recognizes and agrees that any material violation of the provisions of Section 5 of this Agreement
    would cause such damage or injury to the Company as would be irreparable the exact amount of damage would be impossible to
    ascertain; therefore, the Executive agrees that notwithstanding anything to the contrary contained in this Agreement, the
    Company shall be entitled to seek injunctive relief from a court of competent jurisdiction in the jurisdiction and venue in
    which Executive resides to seek an injunction against such violations or threatened violations. Such right to seek an injunction
    shall be cumulative and in addition to, and not in limitation of, any other rights and remedies by the Company may have in
    equity or at law.
	 	 	 
	 	(g)	Governing
    Law. Forum Selection. This Agreement shall be construed in accordance with the laws of the State of New York, United States,
    exclusive of any choice of law principles. In the event any dispute arises between the Parties relative to this Agreement,
    then the dispute shall be litigated in any federal or state court of competent jurisdiction in the City of New York, State
    of New York, United States and both Parties agree to personal jurisdiction in such courts.
	 	 	 
	 	(h)	Currency.
    All currency amounts referenced in this Agreement are in Canadian dollars (gross) unless otherwise expressly stated and all
    payments made to the Executive under this Agreement or in respect of Executive’s employment shall be made subject to
    all applicable statutory deductions and withholdings.

 

    	 	Page
                                         13
                                         of 20

     

    

 

	 	(i)	Entire
    Agreement; Amendments. This Agreement (inclusive of the attached Schedules hereby incorporated by reference), contains
    the entire understanding and agreement of the Parties hereto with respect to the matters contained herein, and may not be
    amended or supplemented at any time unless by writing, executed by each of the said Parties. Any agreement or understanding,
    written or otherwise, prior to the effective date of this Agreement between the Executive and the Company relating to the
    employment of the Executive is hereby terminated and discharged. Notwithstanding anything to the contrary in this Agreement,
    the parties recognize that the obligations under Sections 5.1, 5.4, 5.5 and 5.6 of the Executive Consultant Agreement which
    by their nature are intended to survive the termination of such agreement shall remain in full force and effect and enforceable
    in accordance with their terms. Moreover, all compensation vested in Executive and/or already paid to Executive under the
    Executive Consulting Agreement shall remain due and owing, including securities earned, unless expressly waived in writing.
	 	 	 
	 	(j)	Indemnification
    and Insurance. The Company shall save, defend, indemnify and hold harmless the Executive against all losses (including
    all settlements or judgments), claims, expenses, or other liabilities of any nature arising from or relating to: (a) Executive’s
    employment with the Company or any subsidiary or affiliate of the Company; (b) the conduct of Executive’s job duties
    for the Company or any subsidiary or affiliate; (c) claims asserted against Executive by virtue of his legal capacity as an
    officer, director, consultant, or agent of the Company or any of its subsidiaries or affiliates; (d) the patents assigned
    by Executive to the Company, or its subsidiaries or affiliates; (e) any claim of product liability relating to the drug therapies
    being developed by the Company; (f) any guarantee or alleged joint liability of or for any obligation of the Company or any
    of its subsidiaries or affiliates which may be asserted against Executive. Notwithstanding the foregoing, this indemnity obligation
    shall not apply in respect of any claims that arise from or relate to conduct by the Executive in respect of which the Executive:

 

	 	(1)	did
    not act honestly and in good faith with a view to the best interests of the Company; or,
	 	 	 
	 	(2)	In
    the case of a criminal or administrative action or proceeding that is enforced by a monetary penalty where the Executive did
    not have reasonable grounds for believing that his conduct was lawful.

 

Without
limiting the foregoing, the Executive shall be entitled to payment of all reasonable costs and expenses including attorneys’
fees incurred in the defense of any action or proceeding arising out of his employment and any settlement or judgment. The Executive
shall be entitled to counsel selected by the Company subject to the Executive’s consent, not to be unreasonably withheld.
The Company shall pay any counsel so retained for Executive for all such fees and costs incurred on the terms negotiated with
such counsel. The Company shall pay any settlement or judgment involving or entered against Executive within the time provided
by any settlement agreement or by the Court in which any judgment is entered. The Company also agrees to obtain, on commercially
reasonable terms, such D&O insurance, general liability insurance and other insurance as a prudent comparably sized company
would obtain to protect against liability for any potential claim against Executive.

 

    	 	Page
                                         14
                                         of 20

     

    

 

	 	(k)	Acknowledgement:
    Waiver. The Executive acknowledges that the grant of stock options provided for in Schedule 2 to this Agreement constitutes
    actual, valuable fresh consideration in exchange for signing this Agreement and the Executive hereby waives irrevocably any
    right he may have to assert that this Agreement should be invalid, void or voidable, in whole or in part, for lack of consideration.
	 	 	 
	 	(I)	Counterparts.
    This Agreement may be executed and delivered by the Parties in one or more counterparts, each of which when so executed and
    delivered will be an original, and those counterparts will together constitute one and the same instrument.
	 	 	 
	 	(m)	Execution.
    Execution and delivery of a facsimile or other functionally equivalent means of electronic execution and transmission of this
    Agreement will constitute, for purposes of this Agreement, delivery of an executed original and will be binding upon the Party
    whose signature appears on the transmitted copy. Any Party so executing this Agreement undertakes to originally-execute and
    deliver to the other Parties a copy of this Agreement as soon as possible after such electronic and transmission.

 

    	 	Page
                                         15
                                         of 20

     

    

 

IN
WITNESS WHEREOF, the Parties hereto have executed this Agreement or caused their duly authorized officers to execute this Agreement
on date set forth above.

 

	 	SCYTHIAN
    BIOSCIENCES, CORP.
	 	 
	 	Jonathan
    Gilbert, Chief Executive officer
	 	 
	 	EXECUTIVE
	 	 
	 	David
    Schrader

 

    	 	Page
                                         16
                                         of 20

     

    

 

SCHEDULE
1

REMUNERATION
AND FRINGE BENEFITS

 

	1.	Base
    Salary. As compensation for the services to be rendered by the Executive hereunder, the Company shall pay the Executive
    an annual base salary (the “Base Salary) as follows:

 

	 	(a)	During
    the first year of the Initial Term, Executive shall receive a Base Salary equal to One Hundred and Eighty Thousand Dollars
    (CDN$180,000) per annum.
	 	 	 
	 	(b)	During
    each subsequent year of the Initial Term, the Base Salary sl1all increase by an additional Twenty Thousand Dollars (CON $20,000).
	 	 	 
	 	(c)	The
    salary for any Renewal Term(s) shall be agreed upon by the Parties but shall not be less than the Base Salary for the immediately
    previous year of the Employment Term plus an additional (CON $10,000).
	 	 	 
	 	(d)	The
    Company shall make such payments to the Executive by wire to the bank account information provided by Executive to the Company.
	 	 	 
	 	(e)	In
    the event that the exchange rate between the Canadian dollar and the United State dollar shall change such that the Canadian
    dollar shall become worth less than 0.757 U.S. dollars, the then in effect Base Salary shall be increased such that it shall
    be a minimum of 0.757 U.S dollars for each CON of the Base Salary level. By way of example, if the exchange rate shall become
    0.70 U.S. dollars per Canadian dollar, the Base Salary for year one would be increased to (CDN$180,000 x 757/700 = CDN$194,657).
    This conversion increase shall only apply during any bi weekly pay period in which this decrease in the value of the Canadian
    dollar has occurred and conversion shall be made based upon the lowest US dollar conversion amount applicable during that
    pay period.
	 	 	 
	 	(f)	In
    the event that Executive and Company agrees that Executive’s job shall be converted to a full time position, Executive’s
    Base Compensation shall be negotiated between the parties but shall be no less than CDN$250,000.

 

	2.	Vacation
    Time and Vacation Pay

 

The
Executive will be entitled to Four (4) weeks’ vacation per year to be taken at a time or times acceptable to the Company,
and shall increase at the rate of One (1) week per year annually, to a maximum of Six (6) weeks per year. Accumulated but unused
vacation time may be carried over from year to year. In the event that any such unused vacation time exists at the time of the
Executive’s Termination Date, tl1e Executive shall be compensated for such unused vacation time within 30 days of termination.

 

    	 	Page
                                         17
                                         of 20

     

    

 

	3.	Bonus

 

The
Executive shall be paid an annual bonus (the “Annual Bonus”) equal to the greater of (a) 0.5% of the
Company’s gross revenue for each calendar year or portion thereof during which Executive is employed up to and including
the Termination Date, or (b) 15% of the Executive’s annual salary for the concluding year. Such bonus shall accrue on an
ongoing basis but shall be payable within Thirty (30) days following the conclusion of each twelve month anniversary of the commencement
of this Agreement (each such concluded twelve month period, a “Bonus Period”), subject always to Section 4(f) of the
Agreement.

 

The
Executive shall additionally be eligible for a discretionary bonus to be determined by the Company’s Compensation Committee
which may consist of both cash and stock or other securities of the Company. For greater clarity, the Executive acknowledges that
discretionary bonus is not guaranteed and: (i) whether any discretionary bonus will be awarded, and if so, the amount awarded,
are both fully discretionary to the Compensation Committee; and (ii) the award of any discretionary bonus in respect of any year
does not in any manner entitle the Executive to receive a similar award, or any award, in any other year, nor does it entitle
the Executive to claim any compensation in lieu of such award.

 

The
Executive shall be awarded a bonus of CDN$50,000 upon (a) any new drug R&D program instituted by the Company; and (b) the
grant of an IND by the U.S. FDA in connection with each drug development project, provided that such grant occurs on or before
the Termination Date. Such sum shall be paid within 30 days of the triggering event.

 

The
Executive shall be awarded an bonus of CDN$100,000 upon the grant of an NOA by the U.S. FDA in connection with each drug development
project, provided that such grant occurs on or before the Termination Date. Such sum shall be paid within 30 days of the triggering
event.

 

	4.	Benefits
    and Allowances

 

The
Executive shall be eligible to participate in the Company’s health insurance plan (in the event that the Company adopts
any such plan) with individual and family coverage at the Company’s expense, subject to the terms of that plan as amended
from time to time, on the same basis as the Company’s other senior executives. Or in the case the Company does not adopt
a health insurance plan, the Executive shall be paid a health insurance allowance of CDN$1,000 per month, entitlement to which
ceases on the Termination Date.

 

The
Executive shall be entitled to participate in the Company’s profit sharing and retirement savings plans (in the event that
the Company adopts any such plan(s)), subject to the terms of such plans as amended from time to time, on the same basis as the
Company’s other senior executives. Entitlement to participation ceases on the Termination Date.

 

The
Executive shall be paid both a cell phone allowance of CDN$130 per month and an automobile and parking allowance of CDN$500 per
month, entitlement to which ceases on the Termination Date.

 

	5.	Expenses

 

The
Company shall issue the Executive an American Express and any other appropriate corporate credit card(s) to be used by the Executive
for all reasonable expenses properly incurred in the performance of his duties. The Executive will be reimbursed for all other
reasonable out-of-pocket expenses properly incurred in the fulfillment of his duties as set out in this Agreement, including travel
and entertainment, upon prior approval and presentation of that documentation as the Company may reasonably request and in accordance
wit11 the Company’s standard expense and reimbursement policies.

 

    	 	Page
                                         18
                                         of 20

     

    

 

SCHEDULE
3

FORM
OF RELEASE AGREEMENT

 

GENERAL
RELEASE

 

KNOW
ALL MEN BY THESE PRESENTS:

 

THAT,
DA YID A. SCHRADER, (collectively “First Party”), for and in consideration of the sum of Ten ($10.00) Dollars and/or
other valuable considerations, received from or on behalf of SCYTHIAN BIOSCIENCES, CORP., (collectively “Second Party”),
the receipt whereof is hereby acknowledged.

 

(Wherever
used herein the terms “First Party” and “Second Party” shall include singular and plural, heirs, legal
representatives, and assigns of individuals, and the successors and assigns of corporations, wherever the context so admits or
requires.)

 

With
the exception of the matters identified below as expressly excluded from this General Release (collectively the “Excluded
Matters”), First Party HEREBY remises, releases, acquits, satisfies, and forever discharges the said Second Party, of and
from all other manner of action and actions, cause and causes of action, suits, debts, dues, sums of money, accounts, reckonings,
bonds, bills, specialties, covenants, contracts, controversies, agreements, promises, variances, trespasses, damages, judgments,
executions, claims and demands whatsoever, in law or in equity, which said First Party ever had, now has, or which any personal
representative, successor, heir or assign of said First Party, hereafter can, shall or may have, against said Second Party, for,
upon or by reason of any and all injuries and damages of any and every kind, to both person and property, and also any and all
injuries and damages that may develop in the future, as a result of or in any way relating to First Parties employment with Second
Party. This release shall expressly not include any claims by First Party against Second Party arising out of a breach of the
employment agreement entered into First Party and Second Party. Nothing herein shall act to in any way release the rights of the
First Party in connection with any vested securities that he owns in the Second Party or any affiliate thereof, as well as any
earned or vested but otherwise unpaid compensation.

 

    	 	Page
                                         19
                                         of 20

     

    

 

IN
WITNESS WHEREOF, I have hereunto set my hand and seal this _ day of June, 2017.

 

Signed,
sealed and delivered in the presence of :

 

	 	 	 
	 	 	David
    Schrader

 

STATE
OF FLORIDA

 

SS:
COUNTY OF BROWARD

 

I
HEREBY CERTIFY that on this day, before me, an officer duly authorized in the State aforesaid and in the County aforesaid to take
acknowledgments, personally appeared David Schrader to me known to be the person described herein, or who provided ___________________
as identification, and who executed the foregoing instrument and he acknowledged before me that he executed the same.

 

WITNESS
my hand and official seal in the County and State last aforesaid this _________ day of _________2016.

 

My
Commission Expires:

 

	 	NOTARY PUBLIC, STATE OF FLORIDA

 

    	 	Page
                                         20
                                         of 20

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00274-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00274-of-00352.parquet"}]]